Targeted Therapy Treatment in Turkey
About Targeted Therapy
Key Highlights
-
Precisely attacks cancer cells, often sparing healthy cells for fewer side effects.Personalized treatment based on the specific genetic profile of a patient's tumor.Can be effective for cancers that are resistant to standard chemotherapy or radiation.Often administered orally or via infusion on an outpatient basis.May be used alone or in combination with other treatments like chemotherapy or immunotherapy.
Who is this surgery for?
- Cancers with specific, identifiable genetic mutations or biomarkers (e.g., HER2-positive breast cancer, EGFR-mutant lung cancer).
- Advanced or metastatic cancers where standard treatments have failed or are not suitable.
- As a first-line treatment for certain types of leukemia, lymphoma, and solid tumors.
- To slow cancer progression, shrink tumors, or manage cancer as a chronic condition.
- Adjuvant or neoadjuvant therapy to reduce the risk of cancer recurrence after surgery.
How to prepare
- Comprehensive diagnostic testing, including biopsy and biomarker/genetic analysis of the tumor.
- Review of medical history, current medications, and overall health status by the oncologist.
- Baseline blood tests and imaging scans (like CT or PET scans) to assess the cancer.
- Discussion of the treatment plan, potential benefits, risks, and expected outcomes.
- Arrangements for administration, which may be oral medication or intravenous infusion.
Risks & possible complications
- Skin reactions, such as rash, dryness, or changes in nail and hair growth.
- Gastrointestinal issues like diarrhea, nausea, or liver function changes.
- Potential for high blood pressure or impaired wound healing.
- Risk of heart problems (e.g., with certain HER2-targeted drugs).
- Development of resistance to the therapy over time, requiring a change in treatment.
Recovery & hospital stay
- Most patients receive treatment as outpatients and can resume normal activities shortly after.
- Regular monitoring through blood tests and scans to assess treatment response and side effects.
- Management of side effects with supportive medications as prescribed by the oncologist.
- Maintaining a healthy diet and staying hydrated to help the body cope with treatment.
- Ongoing follow-up appointments to adjust the treatment plan as needed based on efficacy and tolerance.
-
Typical hospital stay:
0 days (typically outpatient)
-
Expected recovery time:
Varies; side effects may be managed over days to weeks
Frequently Asked Questions
If you are considering targeted therapy in Turkey, these questions and answers can help you make a confident, informed decision.
Popular choices for targeted therapy in Turkey include Liv Hospital Ankara, Istinye Üniversitesi Hastanesi Liv, VM Medical Park Pendik Hastanesi, Medical Park Florya, Medical Park Bahçelievler, known for experienced specialists and advanced surgical infrastructure.
Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform targeted therapy. MediFyr helps you compare oncologists and book consultations online.
The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.
Procedure cost in other countries
Here is an overview of how the estimated cost, hospital stay, and recovery time for targeted therapy compare across other countries where we have data.
| Country | Estimated cost range | Typical stay | Recovery time | View details |
|---|---|---|---|---|
| India | USD 551 – USD 3,304 | 0 days (typically outpatient) | ~ Varies; side effects may be managed over days to weeks | Know More |
| Turkey | USD 4,098 – USD 24,587 | 0 days (typically outpatient) | ~ Varies; side effects may be managed over days to weeks | Know More |
Top hospitals for Targeted Therapy in Turkey
These partner hospitals in Turkey have dedicated oncologist teams and experience managing patients undergoing targeted therapy.
Instabul, Turkey
140 Doctors
Anjali Shah, a 42-year-old architect and...
Anjali Shah, a 42-year-old architect and mother of two, was diagnosed with stage IV non-small cell lung cancer (NSCLC) after months of persistent cough and fatigue. A lifelong non-smoker, the diagnosis was a devastating shock. Genetic testing of her tumor revealed an EGFR mutation, making her a candidate for targeted therapy. Her oncologist, Dr. Chen, recommended osimertinib, a pill taken daily at home, explaining it was designed to specifically block the mutated protein driving her cancer. Anjali was terrified of traditional chemotherapy's side effects and clung to this gentler-sounding option. The treatment was remarkably manageable; she experienced some mild rash and diarrhea, but could continue working and caring for her children. Follow-up scans after three months showed significant tumor shrinkage. Emotionally, she moved from a state of profound fear and despair to one of cautious optimism. The targeted therapy felt like a precise, intelligent weapon, giving her back a sense of control and hope for more quality time with her family.
Oncologists for Targeted Therapy
Explore experienced oncologists who regularly perform targeted therapy and provide pre- and post-operative care in Turkey.
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 31 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist
- 22 Years Experience
- Oncologist